Bradley Foster & Sargent Inc Cognition Therapeutics Inc Transaction History
Bradley Foster & Sargent Inc
- $5.64 Billion
- Q1 2025
A detailed history of Bradley Foster & Sargent Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 11,722 shares of CGTX stock, worth $3,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,722Holding current value
$3,047% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
14MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.56 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$573,3980.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$322,1830.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$261,9720.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$158,1810.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $5.9M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...